Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
TITLE OF PRESENTATION
Digitalization and Globalization of Medical DevicesOctober 2018
2
Consolidated ER&D Spending: ER&D spend is highly consolidated among the top 5 OEMs;Imaging and Non-imaging remain primary spend segments.
R&D
Spen
d (in
Bn)
41%R&D spend contribution by Top 5 R&D spenders
32%Next 10 R&D spend contribution
27%R&D spend contribution by Rest of the Companies
Region-wise R&D Spend
Region % of R&D SpendNorth America 59%
Europe 34%APAC 7%
$24 - 25 BnTotal R&D Spend
Ø Global R&D spend is highly consolidated among top 5 R&D spenders
Medical Devices companies à
Source : DRAUP
Dominant Sub-verticalsNon-imaging diagnostics, Surgical, and Prosthetics
Dominant Sub-verticalsImaging and non-imaging diagnostics
Top 10 R&D Spenders
Philips $2.3 – 2.5 Bn
Abbott $2.1 – 2.3 Bn
Medtronic $2.1 – 2.3 Bn
GE Healthcare $1.4 – 1.6 Bn
Siemens Healthineers
$1.3 – 1.5 Bn
Note: Analysis is based on the DRAUP’s proprietary engineering database, updated in Feb 2018
3
Rest of North America
54%
Rest of Europe
14%
India
6%
76k – 77k R&D Headcount
China
4%
Germany
8%
UK
3%
Bay Area
8%
Consolidated R&D Talent Footprint: ~90% of the global engineering workforce is consolidated in North America and Europe.
Medical Devices R&D Footprint
• Medical Devices R&D is consolidated in the United States and is not very globalised.
• Medical Devices OEMs are not leveraging low-cost talent hotspots like India and China.
• Most of the hubs are located in North America, indicating that the decision making is still governed from the US
Hub Spoke AnalysisNorth America Europe APAC
66%
8%
26%
57%
19%
24%
27%
28%
45%
Outpost
Satellite
Hub
Top Players
(by R&D presence)
• Medical Devices R&D is consolidated in the United States and is not very globalized
• India and China are the emerging tech hotspots for medical device Companies.
• Most of the hubs are located in North America, indicating that the decision-making is still governed from the US
Note: Analysis is based on the DRAUP’s proprietary engineering database, updated in Feb 2018 Source : DRAUP
4
Expanding R&D Talent Footprint: Over the past 3 years, OEMs have started expandingR&D globally, especially setting up centers in India and the Bay Area.
Global Medical R&D Center Distribution and Growth
6.4 – 6.5k
39 – 40k
19 – 20k
4.3 – 4.4k 3.4 – 3.5k
CAGR: 3.4%
CAGR: 3.5%
CAGR:20%CAGR: 3%
• Bangalore and NCR are two major hotspots in India for MD investment.
• Suzhou and Shanghai are two major hotspots in China.
• Fresenius, Medtronic, and Thermo Fischerhave opened multiple R&D centers in China since 2009.
• GICs in India are getting empowered and engaging in strategic partnerships with Service Providers.
• Tech Giants are building software-centric solutions out of Bay Area and have developed a rich Medical Device ecosystem.
• Thermo fischer and GE Healthcare have opened software COEs in Bay Area.
• UK has seen a rise in the Medical Device talent in the last 3 years.
2017
2013
CAGR: 8%
Bay Area Rest of USA Europe India China
Note: Analysis is based on the DRAUP’s proprietary engineering database, updated in Feb 2018 Source : DRAUP
5
62% 17% 21%
Medical device Hotspots in US: Increase in the number of digital use cases has led to the emergence of newer digital hotspots in the US
WEST COAST
BAY AREA
PHOENIX
EAST COAST
BOSTON
Hotbeds 2018Emerging Hotbeds
NEW YORK
RALEIGH
ATLANTA
MINNEAPOLIS CHICAGO
11K+ Monitoring, Cloud Analytics,
Genomics, Robotics, Automation
500+Vascular, Pacemakers, Clinical
Diagnostics
GREATER SALT LAKE CITY
1500+Imaging applications, Molecular
Biology, Neurovascular
TEXAS (Austin, Dallas & San Antonio)
1600+Ophthalmology, Surgical,
Neuromodulation, Lenses 800+Surgical Robotics, Oncology,
Ultrasound, Respiratory Devices
700+System Development, Oncology,
Microbiology, Imaging systems
3.4K+Gen-sequencing, Diabetes,
Surgical, Trauma and Extremities
4.5K+Pump Platforms, Mobile CT
scanner, Urology, Endoscopy
2.5K+Ultrasound, Oncology,
Telehealth, Care Delivery4.7K+
Cardiovascular, Navigation,
Patient Monitoring.
44k – 45k US R&D Headcount
46% 39% 15%Traditional
(Mech/Embedded)
Digital ClinicalTraditional
(Mech/Embedded) Digital Clinical
6
~30% of the Medical Devices R&Dtalent in Bay Area is working in Software verticals
300 - 400
200 - 300
500 - 600
100 - 200
Top 5 Medical Devices OEMsbuilding software solutions in Bay Area
Medical Devices OEMs in Bay Area
Note: Analysis is based on the DRAUP’s proprietary engineering database, updated in Feb 2018Source : DRAUP
100 - 200
Future Focus SegmentsCurrent OEM Focus
Punit SuriVP Smart Lab
& Digital ScienceThermoFisher Scientific
Brian StewartSenior Director
Digital EngineeringThermoFisher Scientific
Technology Leaders
Rani PangamSenior DirectorGlobal IT EPMO
Medtronic
Eran RubensChief Technology Officer
Enterprise ImagingThermoFisher Scientific
Non-imaging Diagnostic Non-imaging Diagnostic
Acquisitions
Emerging Focus AreaSoftware-enabled Solutions/WorkloadsCloud Platform for connected health
Automation of Liquid Chromatography
Data Analytics in Non-imaging Diagnostics
Data Interoperability between devices
PCR Cloud Application
Lab Automation
Cloud Bioinformatics solutions
Minimally Invasive devices
Imaging Medical Device
Next generation sequencing
Artificial Pancreas
Genomics
Stem cells
Regenerative medicine
Personalized medicine
West Coast, USA: Medical device giants are setting up software centres in Bay Area in West coast to exploit the strong STEM talent and develop digital use cases
7Note: Analysis is based on the DRAUP’s proprietary engineering database, updated in Feb 2018Source : DRAUP
East Coast, USA: Medical device giants have accelerated capabilities focussed on Product and Systems Development in Boston Area in East Coast
~50% of the Medical Devices R&Dtalent in Boston Area is working in Product and System Development
550 - 600
450 - 500
600 - 650
150 - 200
Top 5 Medical Devices OEMsbuilding software solutions in Bay Area
Medical Devices OEMs in Boston
250 - 300
Future Focus SegmentsCurrent OEM Focus
Jim LaDineVP R&D, Chemical Analysis Division
ThermoFisher Scientific
Technology Leaders
Tom NeufelderSVP, Innovation Leader
- Diagnostic ImagingPhilips Healthcare
Kurt GeitzVice President R&D
Boston Scientific
Acquisitions
Emerging Focus AreaProduct / System Development Workloads• Development of advanced mechatronics products and
systems for Minimally Invasive Surgery
• Development of Mobile CT scanner product for navigated spinal and cranial surgery
• Research and development of Pump Platforms (Mechanical Circulatory Support)
• Development of novel LVAD attachment devices
• Research and development on Rhythmia mapping and navigation system
• Development of ultrasound transducers for diagnostic imaging.
• Research & Development in Mass Spectrometry, Microbiology, Chemical Analysis, Chromatography & Analytical Technologies
• Research and development of Bioprocess Disposable Bioreactor
• Development of custom hardware designs
• Design & Development of Wearable Sensing Solutions
Kevin BourqueVice President R&D
Abbott
8Note: Analysis is based on the DRAUP’s proprietary engineering database, updated in Feb 2018Source : DRAUP
Minneapolis, USA: Giants of Minnesota like Medtronic and Boston Scientific are using mechanical capabilities to build cardiovascular devices and surgical tools
~70% of the Medical Devices R&Dtalent in Minneapolis Area is involved inDevelopment of surgical tools and devices for cardiovascular.
1600-1800
600 - 650
1800 - 2000
30-50
Top 5 Medical Devices OEMsin Minnesota
Medical Devices OEMs in Minneapolis
100 - 150
Future Focus SegmentsCurrent OEM Focus
Technology Leaders
Mike HessVP, MCS Business at
Medtronic
Randy SchiestlVice President R&D
Boston Scientific
Acquisitions
Emerging Focus AreaProduct / System Development Workloads
• Development of a product pipeline for a broad portfolio of endovascular products inclusive of PTA, SFA stenting systems
• Development of MRI conditional implantable pacemaker
• Development of new Guide and Diagnostic Catheter products, Cardiology balloon and intravascular filter products.
• Fabricate & test medical device prototypes of implantable ,surgical tools and machinery
• Development of home health telemonitoring software for mobiles
• Data Management, Cloud Computing. Firmware development and Mechanical Design of
Neuromodulation Patient Care Devices
Vicenta HoffmanSr. Director, Global
Sourcing and Supply Chain, St. Jude Medical
9Note: Analysis is based on the DRAUP’s proprietary engineering database, updated in Feb 2018Source : DRAUP
Chicago, USA: Robotics, Cloud imaging and Digital pathology solutions are key digital focus areas of medical device giants in Chicago
~50% of the Medical Devices R&Dtalent in Chicago Area is involved indevelopment of Renal therapeutic devices
500 - 600
250 - 300
1300 - 1500
100-150
Top 5 Medical Devices OEMsin Chicago
Medical Devices OEMs in Minneapolis
200 - 250
Future Focus SegmentsCurrent OEM Focus
Technology Leaders
Ying-Cheng LoVP, Global Technology and R&D Innovation,
Baxter
George DaileyDirector, Hardware
EngineeringSiemens Healthineers
Acquisitions
Emerging Focus AreaProduct / System Development Workloads
• Design, development, implementation, and analysis of medical products under Renal Home Therapy and Peritoneal Dialysis (PD) devices
• Development of laparoscopic surgical instrument product line
• Product Development of platelet and red blood cell apheresis collection systems
• Development of Sterile Injectables and cellular therapies
• Development frameworks for controlling a wide variety of laboratory instruments, including liquid handling robots, plate storage robots, fluorescence plate readers, radiometric plate and vial readers.
• Cloud imaging, Advanced Visualization (AW), CVIT, Perinatal, Perioperative and Digital Pathology Solutions
10
R&D Spend Distribution: Diagnostics Devices is the prime spend segment; explosive adoption of EMR, Point of Care Solutions and Connected devices are the key growth drivers.
Therapeutic DevicesDiagnostic Devices
Medical Devices
R&D Spend
expected growth rate
5.7%
Medical Devices Global R&D
Spend
$24-25Bn
4.9
5.9
3.3
1.7
5.9
6
6.7
7.6
4.3
2.3
7.6
7.9
Monitoring Devices
Surgical Devices
Imaging Diagnostic
Non-imaging Diagnostic
Other Therapeutic
Prosthetics
2017 2021E
Medical Devices R&D Spend Distribution across sub-verticalsTherapeutic Devices
• Investments in monitoring devices is majorly driven by the demand of connected home care solutions as a part of value-based care.
6.6%
5.5%
5.6%
5.5%
5.3%
5.5%
Diagnostic Devices
Therapeutic Devices Diagnostic Devices
• 60% growth of global EMR adoption in the last 5 years
• Imaging Diagnostics is experiencing maximum growth in R&D spending because of the huge amount of data being generated
• Point of Care solution in non-imaging diagnostics is the major driving force for growth in this segment
Note: Analysis is based on the DRAUP’s proprietary engineering database, updated in Feb 2018 Source : DRAUP
11
Digital Transformation of R&D: Medical Devices R&D spend is expected to reach ~$32BN in the next 5 years, largely driven by investments in digital-centric use cases.
*Analysis of top 32 R&D spenders
G500 Medical Devices R&D Spend (In USD Bn)
$21 -22 $23 -24$24 -25
$31 -32
2015 2016 2017 2022E
Key Digital Transformation Themes
Preventive Care• Enhanced focus on preventive care has warranted
use of predictive analytics• AI, Cyber Security, Bigdata, IoT and combination
products will drive spending on devices
Point-Of-Care (POCT) Testing• Focus on affordable pricing, faster detection, and
reduction in hospital stays are key factors driving consumer device adoption
• Target to reduce the amount of manual labor involved in diagnosing disorders and move from lab to clinic model driving the market for devices
Real-time Monitoring• Increased usage of devices for continuous monitoring
and digital therapeutics have led to higher demand levels of wearables
• Predictive care to manage chronically ill patients and reduce overall visits
Note: Analysis is based on the DRAUP’s proprietary engineering database, updated in Feb 2018 Source : DRAUP
Tech Giants• Google, Microsoft and IBM are capitalizing on their native
capability in new technologies and are disrupting conventional business models.
• Google has acquired a start-up called “DeepMind,” focusing on fast analysis and diagnosis of imaging scans.
Cross-Vertical Applications- Telecom and Aerospace
• Remote Medical Center, Teleconsultation and Teleradiology are gaining investments from Telecom players that will help them expand their service portfolio
• Studies on focused sonography have been performed to meet the diagnostic challenges of space medicine and to discover potential applications of point-of-care ultrasound for the aeromedical clinician
Startups• Start-ups are targeting Artificial Intelligence and
Analytics to enhance the patient experience, increase efficiency of devices, and improve clinical workflow.
• Crospon is developing edge minimally invasive medical devices for imaging and aiding surgery in the esophagus and stomach.
12
12KSoftware
Engineering job openingsAcross 32 OEMs during 2017
20Digital CoEs
set up by OEMs in the last3 years
~11%Expected CAGR (2017-2022) growth
in software sub-segment
64% 19% 17%
33% 33% 33%
60% 20% 20%
40% 27% 33%
64% 19% 17%
Digital (Software/Analytics/ML) Clinical (Non-Engineering)Traditional (Mech/Embedded)
R&D Headcount Split by SkillsOEMS Key Digital CoEs
• San Francisco Bay Area• Milwaukee, US• Bangalore, India
• San Francisco Bay Area• Amsterdam, Netherlands• Bangalore, India
• Minneapolis, US• Los Angeles, US• Hyderabad, India
• Minneapolis, US• San Francisco Bay area• Boston, US
• San Francisco Bay area• Indianapolis, US
R&D spend of medical devices companies: Bay Area and Bangalore are emerging as prime hotspots for Digital CoEs of medical device companies
13
GE Healthcare: Organization R&D structure and workforce distribution
Note : DRAUP’s proprietary talent module was used to analyse job roles by Industry and skill type
~7,000R&D Headcount Traditional (Mech/ Emb.) Digital (S/W, Analytics and ML) Clinical (Non-Engineering)
Key Centres & Workloads
Development of imaging for radiology, fluoroscopy, interventional cardiology, angiography, electrophysiology and mammographyDevelopment of patient monitors, Positron Emission Tomography systems
Greater Milwaukee area
~4,500 ~1300 ~1200
Development of GE health cloudSan Francisco Bay Area
Greater Boston Area
R&D talent employed by GE Healthcare across 42 centres globally Life sciences solutions such as Cancer
diagnostic and molecular imaging methods for biopharmaceuticals cancer research
Greater New York City Area
Greater Chicago AreaDevelopment of PACS, Cardiovascular Information System (CVIS), Radiology Information System (RIS), , cloud imaging, Advanced Visualization (AW), Perinatal, Perioperative and digital pathology solutions
Burlington, Vermont AreaDevelopment of next-gen imaging application in emerging web technologies such as HTML5, CSS3, AngularJS, jQuery and associated testing products such as Jasmine
FranceHigh-quality imaging and hybrid workspace operating room
BengaluruDevelopment of CT, MR, molecular imaging, ultrasound, x-ray and patient monitoring products and servicesDevelopment of Perinatal products, High Acuity care products and radiology imaging products Bengaluru
Digital Radiography, Women's Health & Interventional Radiology
Baltimore, Maryland Area Florence, South Carolina Area Phoenix, Arizona Area
Madison, Wisconsin Area Germany
Research and development of Bioprocess business
United KingdomResearch on Genomics and Cellular; Develop the newest generation of medical diagnostic products and contrast media
SwedenDevelopment of chromatography media
NorwayMicrobiological methods for use in production line of injectable drug products
ChinaDevelopment of CT and X-RAY detector,Value Mammography product
Greater Salt Lake City AreaGreater Seattle Area
HungaryIsrael
14
Philips: Organization R&D structure and workforce distribution
Note : DRAUP’s proprietary talent module was used to analyse job roles by Industry and skill type
~7,500R&D Headcount Traditional (Mech/ Emb.) Digital (S/W, Analytics and ML) Clinical (Non-Engineering)
Key Centres &
Workloads
~2,500 ~2,500 ~2,500
Development and testing of PACS (Picture Archiving Communication Systems) Development of architecture to build the cloud based Philips HealthSuite Digital Platform
San Francisco Bay Area
R&D talent employed by Philips across 32 centres globally Development of interventional oncology business line with
products such as UroNav (an image-guided stereotactic biopsy system)
San Francisco Bay Area
Development of image-analysis algorithms & system design for ultrasoundDesign of the interface between the ultrasound imaging system and transducerDesign and development of multi-tier objected-oriented components & functionality for a global, large-scale secure critical care clinical information system
Greater Boston Area
Design of clinically viable wearable medical devices for remote patient monitoring (Ex-Telemetry medical devices) Design therapy delivery subsection for Philips ALS (amyotrophic lateral sclerosis) defibrillators
Greater Boston Area
Define, design and build innovative clinical MRI (magnetic resonance imaging) solutions Research on clinical risk algorithms and clinical decision support systems Research in unobtrusive neonatal monitoring & accelerometry for vital sign monitoring Development of the clinical roadmap with respect to fMRI (Functional MRI) and neurosciences
Netherlands
Development of workflow software for Computer Tomography (CT) imaging applicationConcept design, development and industrialization of Microdose, an advanced mammography solutionR&D of image processing and analysis algorithms for radiation therapy treatment
Bengaluru Advanced development of technology solutions to expand CT (computed tomography) spectral imaging capability Long term research in virtual colonoscopy and virtual catheterization applications
Israel
Development of new for home healthcare in field of respiratory care, sleep care & COPD (chronic obstructive pulmonary disease)Project lifecycle management of new mask development and optimization of existing masks
Greater Pittsburgh Area
Design, development and industrialization of Intuis, an entry level interventional X-ray systemNew product development & lifecycle management of cardiovascular cathlab productsDesign & development of mechanical sub-assemblies for surgery C-Arms
Pune
Greater Seattle Area
Greater San Diego Area
Germany
Brazil
Cleveland
United Kingdom
France
China
15
Medtronic: Organization R&D structure and workforce distribution
Note : DRAUP’s proprietary talent module was used to analyse job roles by Industry and skill type
~7,500R&D Headcount Traditional (Mech/ Emb.) Digital (S/W, Analytics and ML) Clinical (Non-Engineering)
Key Centres & Workloads
~4,500 ~1,500 ~1,500R&D talent employed by Medtronic across 41 centres globally Firmware development and mechanical design of
Medtronic Neuromodulation Patient Care DevicesMechanical designs for Cardiac Rhythm and Heart Failure (CRHF) business units, inclusive of Implantable Cardio Defibrillators (ICDs) and Implantable Pulse Generators (IPGs)Analog IC design and development for Medtronic CRHF products
Greater Minneapolis Area
R&D on Aortic and Peripheral devicesR&D on Spine and Oncology procedures, radiofrequency (RF) ablation of metastatic malignant lesions in the vertebral body, spine pain management and interventional oncology, RF bipolar ablation probes, bone biopsy & efficient Pedicle/Cortical Wall access systems
Bay Area
Development of advanced mechatronics products and systems for Minimally Invasive Surgery with a focus is on embedded software for the MIS platform’s robotic subsystem
Greater Boston Area
Greater New York Area
JacksonvilleGreater St. Louis AreaGreater Memphis Area
Software development and design in Respiratory and Monitoring Solutions, Ventilators division
Greater San Diego Area
Design and development of ventilator software with C++ and C# on WinCE and ThreadX, QT on Linux
China
Research and Development of a catheter delivery system for coronary stents
Ireland
Research and Development on hernia repair medical devices and anti-microbial surgical implantResearch and Development in a critical medical equipment sector - Respiratory Unit
France
Concept Design, Analysis, Software development for Early Technologies, Patient Monitoring and RecoveryAdvanced Development, algorithm development, and new technology research for the Medtronic Navigation business
Greater Denver Area
Design and development of mechanical surgical devices in the areas of Thoracic Surgery, Hernia Repair, Minimally Invasive Surgery
India
Greater Memphis Area
Israel
Denmark
Development of Microstream capnography modules, in conjunction with specialized algorithms, as well as CO2 breath sampling lines
16
Abbott: Organization R&D structure and workforce distribution
Note : DRAUP’s proprietary talent module was used to analyse job roles by Industry and skill type
~3,000R&D Headcount Traditional (Mech/ Emb.) Digital (S/W, Analytics and ML) Clinical (Non-Engineering)
Key Centres & Workloads
~1,200 ~8,00 ~1,000R&D talent employed by Abbott across 16 centres globally Development of mechanical circulatory systems,
i.e., blood and implantable heart pumpDevelopment of mechanical circulatory support devices for Left Ventricular Assist DeviceDevelopment of embedded firmware and related applications to support new product development for blood glucose monitoring systems
San Francisco Bay AreaDevelopment of software for implantable ventricular assist devices
Greater Boston Area
Development of leading LIS (Laboratory Information System) product Development of STARLIMS V10.5 using technologies such as JavaScript, .Net in the client side and SSL (STARLIMS Scripting Language) for the server side.
Israel
Development of image guided therapy platforms and technologiesDevelopment and testing for surgical and transcatheter valve testingTechnology development in the area of transcatheter & surgical heart valves and vascular closure
Greater Minneapolis – St. Paul Area
Greater Chicago AreaDevelopment of specifications to release materials (reagents, controls and calibrators)Research, development and technical product support with particular emphasis on infectious disease diagnostics
Texas Area
Product development of class III medical devices for neuromodulation therapy: spinal cord stimulation, deep brain stimulation, and dorsal root ganglion stimulation
United KingdomClinical research associated with Abbott’s Diabetes care productsGermany
Research and manufacturing site for Abbott Vascular Instruments, molecular diagnostics and informatics implementationsProducts developed and produced include balloon dilatation catheters and stent systems
ChinaScientists conduct research and develop products for diagnosing and managing major cardiovascular, endocrine and metabolic diseasesInnovation and acceleration associated with the discovery of new diagnostic tools using a multi-disciplinary, collaborative approach
Testing methods to identify, measure and mitigate MRI induced mechanical hazards including considerations for static force, torque and gradient vibration
Greater Los Angeles Area
17
Roche: Organization R&D structure and workforce distribution
Note : DRAUP’s proprietary talent module was used to analyse job roles by Industry and skill type
~4,500R&D Headcount Traditional (Mech/ Emb.) Digital (S/W, Analytics and ML) Clinical (Non-Engineering)
Key Centres & Workloads
~2,500 ~500 ~1,500R&D talent employed by Roche across 11centres globally
TucsonCore research that encompass chemistry, multiplexing, molecular and advanced systemsResearch and development of key initiatives with a focus on product development including lean workflow solutions, *IHC assay development, *ISH assay development and detection system (reagent) development.
IndianapolisFocus on global information management systems within the Diabetes Care spaceResearch and development of software systems like Accu-Chek 360 and handheld glucose measurement systems such as Accu-Chek Aviva and Accu-Chek for the management of diabetes
MadisonResearching and manufacturing target enrichment probe pools for *DNA sequencingNext generation sequencing combined with sequence capture probe poolsResearching genomic structure to understand the impact of genes on biological processes
SwitzerlandCenter of expertise in modern instrument designDevelopment, production and servicing of instruments and software systems that are used in in vitro diagnostics
Bay AreaDevelop a single-molecule, semiconductor based, *DNA sequencing platform using nanopore technologyDevelop and deliver testing services to perform directed analysis of cell free *DNA in blood
South AfricaDevelops life science reagents for DNA and RNA amplification, sequencing and molecular diagnostics
GermanyResearch and development of in vitro diagnostics productsDevelopment of compounds for Roche lab analyserplatforms
Bay AreaLab automation, workflow, and LIMS software for the NIPT CLIA Lab in San Jose.Develop, deploy and manage software and bioinformatics services on the cloud.Software development, integration and testing for In-Vitro Diagnostics (IVD) medium throughput solution for qualitative & quantitative detection of molecular targets
18
Emerging Medical device companies Dashboard: Ophthalmology, Cardiology, Wearables and Robotics based solutions are key focus areas
Imaging Non-imaging Monitoring Prosthetics Other Therapeutics Surgical
Note: Analysis is based on the DRAUP’s vendor ecosystem module, updated in July, 2018
MRS technology to measure brain metabolites
MRI
ADV
ANCE
MEN
TS
Treat inoperable and hard-to-reach brain lesions using MRI
OPH
THAL
MO
LOGY Provide clinicians a treatment
based decision algorithm
Ophthalmic diagnostic equipment & eye surgical
instruments.
3D M
ODE
L
Analysis of blockages using 3D model of Coronary arteries
DRU
G DE
LIVE
RY Patch pump for subcutaneous delivery of one or more medications
Solving the challenge of self-administering biological medicines
DIAL
YSIS
Tablo-Hemodialysis System, a dialysis machine that can be
used in home or clinic
UltraStream™ Dialysis Catheters
OPH
THAL
MO
LOGY
Ophthalmic biopharmaceutical company treating glaucoma and
other eye diseases
ROBO
TICS Developed highly intuitive
surgical system called Da Vinci.
Identifies potentials in minimally invasive surgery using Robotics
SURG
ICAL
GEL
S
Gels and Bandages for surgical wound treatments that enable
quick blood arrest
CARP
AL S
URG
ERY
Treat carpal tunnel syndrome in a novel fashion, termed Micro-invasive Carpal Tunnel Release
POIN
T-O
F-CA
RE Develop novel sensing technologies for use in
hospital point of care devices
Revolutionizing doctor-patient interaction and
enhancing care coordination
WEA
RABL
ESDeveloped LOOP a wearable that communicates vitals to
clinicians
Wearable that records vitals like heart rate, ECG, Skin
temperature etc.
CARD
IOLO
GY
Developed the world’s largest cardiac data network
WEA
RABL
ES
Wearable sensory prosthesis for patients suffering from balance problems due to peripheral neuropathy
HOLO
GRAP
HY
Developed a proprietary laser-based high-resolution
holographic printing technology.
CARD
IOLO
GYDeveloping a novel
minimally invasive solution for the treatment of mitral
regurgitation (MR)
NAN
OTE
CHN
OLO
GY
Battery powered modular platform to conduct cost-effective diagnostic tests
GEN
OM
ICS
Genome sequencing & machine learning to
modernize infectious disease diagnosis
ROBO
TICS
Introduced Robot-assisted VEM therapy
19
Medical Device OEM Partnerships: Tech Giants, Start-ups, and Service Providers are at the forefront of building digital-first solutions
• Tech giants are partnering with medical device OEMs for off-the-shelf platforms for data collection, processing and Analytics. IBM Watson and Microsoft Azure are notable examples.
• Technology Giants such as Google, IBM and Microsoft are heavily investing in medical devices to enable software-based use cases and disrupting traditional verticals like Monitoring and Imaging Diagnostics.
Technology Giants: Medical equipment companies partner for Software Platforms
Start-ups: Medical OEMs are investing on startups that offer an end to end digital solution.2
• Start-ups are disrupting healthcare value chain to innovate new value segments within deep-domain modalities
• 5 Unicorns have been born in the last 3 years across global locations• Most start-ups are targeting Artificial Intelligence and Analytics to attract investments from OEMs
through end to end digital use case solutions.
Service Providers: Medical OEMs are looking to partner with SPs that encompass high level domain and technical skills to solve Software testing and development challenges3• Service providers need to develop test automation frameworks that can cater the medical OEMs
need to reduce cost, improve efficiency and reduce time to market• Data sanitization and data lake creation is the first level expectation of medical OEMs from their
service partners that can help them generate insights and elevate towards AI solutions.• Service providers have lot of opportunities to develop applications for individual use cases like
monitoring both in patient as well as clinical sides.
Strategic Partnerships with External Support Ecosystem : Tech Giants, Start-ups and SPs
1
Source : DRAUP
Strategic Partnerships of Medical Device OEMs in the Ecosystem
Tech Giants
Startups
20
Tech-Giants: Medical device companies are capitalizing the off-the-shelf analytics platforms developed by Tech Giants like Microsoft and IBM.
Diabetes Care
Chronic Disease Diagnosis
Population Health Management
Connected Health
Point-of-care (POC) Solutions
Key Activities and workloads
To combine the information Medtronic technology gathers with Watson’s ability to examine it, and discover new methods that can advance the treatment of diabetes.
Note: Analysis is based on the DRAUP’s proprietary engineering database
The Medtronic Intellis implant pairs with a Samsung tablet that runs the app that communicates with, and helps control, the device.
Siemens Healthineers will offer PHM solutions and services from IBM Watson Health. This will help in value-based care analytics and reporting and patient engagement.
Building physical products that help patients to thinking about how those products can capture valuable data that provides insight not only into the delivery of care, but into how to improve safety and care delivery.
The companies will jointly design, develop, and market new POC solutions in areas like detection of sepsis and therapeutic drug monitoring as well as the detection of cardiac problems and women’s health conditions.
Use-Cases Partnership
21
Startup investments and acquisitions: Startups that develop end to end use case solutions
in monitoring and Non-imaging devices are prime targets of investments
Imaging Non-imaging Monitoring Prosthetics Other Therapeutics Surgical Key Takeaway
Focussed on the portfolio expansion of imaging devices portfolio
Focused on remote monitoring and data analytics based solutions
Focused on expanding medical device portfolio that enable diagnosis of specific diseases like respiratory and stomach
Highly focused on solutions and devices that help in the diagnosis and treatment of cardiovascular diseases
Focused on remote monitoring and data analytics based solutions
Acquisition Investment
Note: Analysis is based on the DRAUP’s vendor ecosystem module, updated in July, 2018
Focused on the development
of minimally invasive
therapies for the treatment of
mitral regurgitation
Developed a novel 3D
analysis and mapping
system to diagnose variety
of arrhythmias
Focused on the
development of products
for endovascular and
interventional applications.
Treats patients with
debilitating inflammatory
diseases using implantable
bioelectronic devices
Developing edge minimally
invasive medical devices for
imaging and aiding surgery in
the esophagus and stomach.
Provides minimally-invasive
devices for the treatment of
brain aneurysms and
strokes.
Aircraft Medical specializes in
the manufacture of video
laryngoscopes that simplifies
challenging intubations.
AEGEA Medical Inc.
manufactures surgical and
medical instruments.
Fire1 focuses on
developing novel remote
monitoring devices.
Product development of
SMART medication
adherence monitoring and
on a propofol monitor
Nightbalance has created
a device called the Sleep
Position Trainer
Develops MR-guided
Ultrasound technology
devices for image-guided
acoustic surgery.
Viewics provides healthcare
data to surface actionable
intelligence and empower
data-driven. decision-making
Affimed Therapeutics is
focused on developing
recombinant antibody
therapeutics for the treatment
of cancer and other diseases
Insightec
Crospon
Xhale
Medina Fire1 Aircraft Medical AEGEA Medical
Nightbalance
Topera Setpoint Medical IDEV Tendyn
AffimedViewics
22
Technology Service Providers, with their expertise in new age technology and no IP conflicts, are emerging as mature digital partners to OEMs.
Serv
ice P
rovi
der H
eadc
ountà
41%Revenue Contribution by
Top 5 vendors
37%Next 20 R&D spend contribution
22%R&D spend contribution by Rest of the Companies
~$2 Bn – $2.5 Bn
Medical Devices Outsourcing (USD)
Engineering Services companiesà
Source : DRAUP
Dominant sub-verticalsNon-imaging diagnostics, Surgical, and Prosthetics
Dominant sub-verticalsImaging and Non-imaging
Diagnostics
Dominant sub-verticalsImaging and Non-imaging
Diagnostics
Top 5 vendors
Vendor % of Revenue
Capgemini 11.9%
Wipro 8.8%
HCL 8.7%
TCS 8.1%
Quest 3.7%
Recent Significant Deals
Design and implementation of software for low energy device used for continuous blood glucose monitoring.
Development and Testing of the mobile application and other features of Roche’s Diagnostic Products.
Tech Giants Start-ups Service Providers
Note: Data curated by DRAUP Outsourcing module and updated in Feb 2018
23
~40%Total revenue share of Top 5
SPs fromImaging Diagnostics
30%
55%
20%
18%
80%
10%
15%
10%
2%
10%
15%
35%
6%
20%
12%
2%
9%
40%
13%
8%
1%
30%
25%
5%
25%
4%
Imaging Diagnostics Non-Imaging DiagnosticsMonitoring SurgicalProsthetics Other Therapeutics
Revenue split of Top 5 Medical Device SPs(FY 2017)
Key Clients
Top 5 SPs: Imaging diagnostic sub-vertical contributes for more than 40% of the revenue amongst Top 5 SPs
24
Leading Opportunity Areas for SPs
Source : DRAUP*Capability here has been generalized basis standard offerings of some of the Mid-Sized SPs in Medical Devices space
Note: Analysis is based on the DRAUP’s proprietary engineering database, updated in Feb 2018
Bubble size denotes
addressable opportunity
Outsourcing Propensity
• Current Outsourcing Level
• Compete Intensity
• Future Growth Potential
• Ease of Outsourcing
Capabilities (Industry view - Mid Sized SPs)
• Capability (resources/skill set)
• Maturity (Medical Devices relevant experience)
• Solutions / Frameworks / Accelerators
• Adjacency & Scalability
Limited Focus Niche Skills
Investment Focus
Immediate Offerings
*Capability Matrix
Ou
tso
urc
ing
P
rop
en
sit
y
Low
High
High
Data Analytics and Cloud Management
Security
Test Automation
Device Drivers Development
Embedded Engineering
(SW)
Functional Testing
Sustenance Engineering
App development (Web & Mobile)
Embedded Engineering (HW)
E2E Imaging Development
PACS Testing
UI/UX
Opportunities with maximum traction
from OEMs
Non-Functional
Testing
Opportunities to be pursued with a
more services driven approach
Opportunities to be pursued with a
more solution driven approach
25
Opportunity Propensity across sub-verticals
Source : DRAUPNote: Analysis is based on the DRAUP’s proprietary engineering database, updated in Feb 2018
# Opportunity AreasImaging
Diagnostics($M)
Monitoring($M)
Non Imaging Diagnostics
($M)
Other Therapeutic($M)
Surgical($M)
Prosthetics($M)
1 Sustenance Engineering
2 Embedded Engineering (SW)
3 Functional Testing
4 Embedded Engineering (HW)
5 UI / UX
6 E2E Imaging Development
7 Device Drivers Development
8 Security
9 Non-Functional Testing
10 Data Analytics & Cloud Management
11 App Development (Web and Mobile)
12 Test Automation
13 PACS Testing
High Medium Low Not Relevant
26
Majority of these opportunities with Medical Devices OEMS are being addressed by service providers in a pure services driven approach (1/2)
Functional Testing
Testing of ABL90 FLEX analyzer. A Simulator is developed to simulate the functionality of the analyzer.• Execution of Test cases and Test
Scenarios for functional Testing.• Preparation of Test Plan for
functional Testing.• Defect Reporting and tracking using
PVCS.• Preparation of reports for execution.• Bug fixing
• Involved in Test Design, Test Development and Review of test cases.
• Involved in the end to end functional testing.
• Test case creation and execution. Executing the designed scripts using Tanto Script Runner (an In-house tool)
• Capture URS, PRS requirements into ALM
• Create System Design Verification Procedures
• Manage PRS requirements in ALM • Execute test cases in ALM • Generate test reports from ALM and
provide traceability matrix
Non-Functional Testing
• Support and Troubleshoot LATITUDE Remote Monitoring Systems.
• Test, Monitor and troubleshoot the connection between sensors, Pacemaker, communicator and other medical device.
Embedded Software Embedded Hardware UI/UX
• An optional alternative to the Freestyle Libre reader that enables a customer to scan their Freestyle Libre sensor with a compatible smartphone
• Class III App, receives data from the sensor via BLE, displays current glucose, trend arrow and 3, 6, 12 and 24 hours views of the recent glucose history trace.
• Features configurable alerts triggered by different glucose conditions
• Development of Critical Embedded Medical Devices.
• Agile based Sprint methodology. • Tools: Incredibuild, Momentics, SVN
Version tool, Python Editing, Microsoft Visual Studio
• New product design in the field of Patient handling and Electronic packaging of electronic modules for MRI Scanners
• Design assessments, adherence of subsystems to regulatory requirements, guiding global teams towards design change, production parts acceptance assessment and verification strategies
• FDA, GMED & Internal QMS audits
• Develop user interface, workflow, and system requirements for ultrasound imaging applications such as 3D, Contrast Imaging, color Doppler imaging on the Philips Epiq5 and Epiq 7 products
• Analysis, UI Screen Design and Testing of the Ipad Apllication used by Medical Representatives to order certain medical devices and sets for the registered hospitals.
• Unit Testing and System testing for the various modules of Glucose Monitoring System
• Development and testing of code for upgradation & bug fix
• Deploy application in SIT and UAT environments
27
PACS Testing
• Involved in testing of Philips PACS (picture archiving and communication system ).
• Testing PACS four major components: The imaging modalities such as X-ray plain film (PF), computed tomography (CT) and magnetic resonance imaging (MRI), a secured network for the transmission of patient information
• Verification & Validation of Ultrasound Scanner Device
• PACS Application• GE Asset Management Application
E2E Imaging Device Driver Development Sustenance Engineering Security
• Validation of product security of X-ray machine. Product security is attained by applying STIGS (cybersecurity methodology) and security testing is performed on real time machine and software bench using Linux commands
• Modify/Add Siemens custom device drivers to support new WES-7 OS.
• Change all executables of RP500 application to support Raima-12
• Creating Philips' next radiology imaging viewer.
• Altran is responsible for part of the design process, interaction and visual design of the product.
• Developing User console and related software components for GE Healthcare's nextGen Revolution CT-scan machines.
• These machines provide uncompromised image quality and clinical capabilities by converging coverage, spatial resolution, temporal resolution and spectral imaging all in one system.
• Corrective and evolutionary maintenance of the COBAS application Infinity Central Lab Solutions Intersystem using CachObject Script, HTML, CSS, XML, JavaScript, JQuery, Java, Apache, VM, TFS
• Developing an RMS PROServicewhich is a remote service tool, that is used to resolve clinical instrument issues immediately & protect instruments from data security & virus threats.
Majority of these opportunities with Medical Devices OEMS are being addressed by service providers in a pure services driven approach (2/2)
• Enhancement of patient registration algorithms and new hardware support for better performance in computation and heavy volume rendering
• Infosys helps Boston Scientific in Value Engineering of medical devices like Monitoring Systems, Implants and Neuromodulation products
Test Automation: Increase in pressure on Medical Device companies to enhance efficiency & reduce time -to-market is driving them to partner with SPs having strong automation offerings in the medical domain
Medical Device OEMs
Requirement
Reduced cost of operations
Enhanced environment
efficiency
Reduction in Time-to-market
Reusable and Modular
Test environment as a service model
Elimination of errors
OfferingFeatures Support Monitoring & Imaging Devices
Open Source Tools
ThermometerBlood pressure
monitorsGlucometers CT & MRI Sonography
Offering Demand
Mobility TestApplication Test : OS : Android, iOS, Responsiveness Test, Interruption Test, Installation Test,Browser Compatibility Test : Chrome, Safari, Mozilla, Device Compatibility Test
Web ApplicationClient Server Architecture –Cloud based Test (AWS), Web Browser Compatibility, Resolution, Feature Validation, Navigation, Session Timeout, User and Data Security
UI & UsabilityUser Friendliness – GUI standards, Look and Feel, Navigation, Workflow, Keyboard shortcuts, Font, Usability based on User Roles
Offering Workload
1. Test Management• Test setup /
configuration• Test flow creation• Test case creation
2. Test Execution• Execution Engine• Monitoring• Alarms/Events algorithm
3. Analysis & Reporting
• Analysis• Custom reports• Dashboarding
Development of the Automated Test Equipment (ATE) on LabVIEW-2013 to test the software of the new Defibrillator Product. Testing of software on defibrillator hardware board.
Test Automation Case Study
• Creation and execution of automation BPT test cases using Automation tool QTP
• Updating and optimization of automation BPT test cases
• Analyze, report bugs of the failed Test cases • Updating Object Repository as per the
recent changes in application
• Web Service testing of REST API s using automation tool WinECD and SoapUI
• Writing automation scripts (in xml) using WinECD simulator (Philips home-grown).
• Writing and execution of test cases which includes testing of functionality and performance of the services.
Test
Au
tom
ati
on
Op
po
rtu
nit
y
29
Data Analytics as a Service: With an increase in adoption of Digital Health, Medical Device companies are collaborating with SPs having complete analytics workflow expertise to help them in their digital journey (Majority focus on Data Sanitization & Data Lake Creation)
Source: Zinnov Research & Analysis
Data SourcesMedical Devices
Social Media EMR Back-office
Systems Lab Pharmacy Medical Images
Data CollectionDatabase like
NoSQL
Data Processing
Data Streaming
Cloud Storage
Data sanitization and processingData formats (Image, Text, Voice etc.)
Source backgrounds
Open Source Processing Tools
Data lake creation for Use-casesTreatment
Recommendation ML for Illness
Detection Claim Processing EMR/ Patient Analytics
Nursing/ Staffing Scan/ X-ray Analysis
Disease Discovery
Clinical Care Analytics
InsightsData
ExplorationDashboard
Development Analytics AI/ML Applications Alerts
StakeholdersPatients Doctors Hospital Regulators Clinics Payers Researcher
Dat
a an
alyt
ics
Offe
ring
(Com
plet
e W
orkf
low
) Data Analytics Case Study
• Development of application to collect data from source.• Analyse & transform data developing an optimised
dashboard that are used by hospitals in improving the efficiency of operations involved in end to end process w.r.t. ECG & its diagnosis.
• Involved in migration of OBIEE report, dashboards and BIP reports from Integration to Production and Development to Production Analytics.
• Formatting the reports by applying filters and prompts appropriately.
• Modify existing reports and platforms and sanitize the datasets to create insights
• Worked on Data level security by giving permission on catalog objects and Security Tool.
• Unit testing of the reports, validated the data and prepared the documentation for the same with test cases.
30
APP Development: Increase in number of point care devices and adoption of remote monitoring is driving OEMs to partner with SPs to develop mobile/web applications that integrate multiple devices enhancing usability & interoperability of data.
Health Monitoring Devices
ThermometerBlood pressure
monitors Glucometers Weight scale Steps measurement
AnalyseUse Cases
UI/UXDesign
Development
Testing
web
/Mob
ile A
pp
Dev
elop
men
t
Deployment
Glucose Temperature Heartbeat Blood Pressure
Sketch Adobe XD
• UI Wireframing • Prototyping
Cloud & Data Centres
• Functional• Performance
• Installation• Interruption
• Memory• Usability
• Enhancements• Bug fixes
• Quality Assurance
• Project management
• Data Analytics• Data Verification
• Extraction and Classification
• Storage and Bandwidth
Clinical Applications
• Home Health monitoring
• EHR System • PHR application
• Application for hemodialysis machine to collect and display the data received from an electro mechanical subsystem
• Development & testing of application that allows patients track glucose levels and physical activity data using a mobile device
• Development of Mobile Application for real time monitoring of ECG Signal.
• Signal Analysis and Development of framework for testing the application.
• Deploying and supporting DoseWatch, a software solution developed by GE HealthCare.
• Upgrading customers' software installation and providing technical support to customers worldwide.
App Development Case Study
32
Web-based software platformdesigned to make MRStechnology accessible toclinicians and researchersalike. The software combinesa linear combinations modelbased post-processing back-end that represents the mostaccurate method of measuringbrain metabolites with a highlyintuitive and user-friendlyfront-end web-based userinterface
MRI ADVANCEMENTS
Develops technology thatenables neurosurgeons totreat inoperable and hard-to-reach brain lesions using MRI-guided ablation
OPTHALMOLOGY IMAGING
Using OCTA technology,Optovue technologies provideclinicians with information sonew, they demand a differentapproach to treatmentdecision algorithms.
Accutome offers ophthalmicdiagnostic equipment, eyesurgical instruments & clinicalmedications.
OPTICAL IMAGING
Currently addressing ophthalmicmarket needs by providingequipment for early diagnosis,targeted treatment andtreatment monitoring.
3D TECHNOLOGIES
Using data from a standardCT scan, the non-invasiveHeartFlow Analysis creates apersonalized 3D model of thecoronary arteries andanalyzes the impact thatblockages have on blood flow.
Imaging Diagnostics: Emerging Players
33
DIALYSIS
Designed the Tablo-Hemodialysis System, adialysis machine that offerswater purification and createsdialysate, enabling its use inthe home or in the clinic.
Argon Medical develops rangeof medical devices thatOPTION™ Vena Cava Filter,CLEANER™ RotationalThrombectomy System andUltraStream™ DialysisCatheters
DRUG DELIVERY
Evopump developed byCamMed is the first bandage-like patch pump forsubcutaneous delivery of oneor more medications
Clinical stage, privatelyfunded, medical devicecompany focused onadvanced drug delivery andsolving the challenge of self-administering biologicalmedicines
NEUROLOGY
By introducing robot-assistedtherapy to the ICU, REACTIVE-ROBOTICS support therapistsand nurses to provide theoptimal VEM therapy to theirpatients.
OPHTALMOLOGY
Clinical stage, ophthalmicbiopharmaceutical companytransforming the delivery oftherapeutics for the treatment ofprominent eye diseases, suchas glaucoma, dry eyes, allergiceye disease and many others
Therapeutics: Emerging Players
34
Developed the SX-OneMicroKnife® with MeerkatTechnology® to treat carpaltunnel syndrome in a novelfashion, termed Micro-invasiveCarpal Tunnel Release.
CARPAL SURGERY
Using safe, naturally occurringbiomaterials, gel-e designswound treatments for a varietyof applications and patients,spanning from surgical gels tobandages for patients onblood-thinners experiencingroutine nuisance bleeds.
SURGICAL GELS ROBOTICS
The da Vinci systemdeveloped by intuitive surgicalperforms various minimallyinvasive surgeries, with awealth of regulatory approvalscovering a wide spectrum ofsurgical procedures—muchgreater than any of its currentcompetitors on the market.
Together with surgeons thecompany identifies potentialsin minimally invasive surgery,which can be unlocked withthe help of robotics. Thesepotentials may apply toefficiency, safety or trainingaspects as well as to thedevelopment of surgicaltechniques
Surgical: Emerging Players
35
Develop novel sensingtechnologies for use inhospital point of care devices.These devices hold thepotential to identify andmonitor patients at risk ofdeveloping life-threateningconditions at a very earlystage.
POINT-OF-CARE SOLUTIONS
Patientory is empoweringpeople to take charge of theirown health revolutionizing theway doctors and patientsinteract and gain access toinformation, cutting out alllayers and processes thatcurrently are stumbling blocksin care coordination.
REMOTE MONITORING
Offers the VitalConnectPlatform, along with wearablebiosensor that give users andclinicians highly accuratemonitoring and recordingcapabilities for metrics likerespiratory rate, heart rate,heart rate variability, single-lead electrocardiogram, skintemperature, and more.
CARDIOLOGY
Developed the world’s largestcardiac data network, makingcare more accurate,comprehensive and efficient.
Developing transformativedigital health solutions thatenable patients to get the rightcare at the right time. Loopfrom Spry Health Monitorsvitals while you go about yourdaily life & Communicatesrelevant health & fitnessfeedback
Monitoring: Emerging Players
36
Medical device company
developing a novel minimally
invasive solution for the
treatment of mitral
regurgitation (MR)
MITRAL REGURGITATION (MR)
Prellis Biologics, Inc. has
developed a proprietary ultra-
fast laser-based high-
resolution holographic printing
technology.
HOLOGRAPHY
RxFunction develops walkasins –
a wearable sensory prosthesis
with the goal to return patients to
a lifestyle of confidence and
mobility. Walkasins aid in
balance improvement, enabling
doctors to prescribe a wearable
device to patients suffering from
balance problems due to
peripheral neuropathy.
WEARABLES
The Axonics Sacral
Neuromodulation System™ is
the first CE-marked
rechargeable SNM system
designed to improve the
experience of both clinicians
and patients suffering from
Urinary and Fecal dysfunction.
NEUROLOGY
Prosthetics: Emerging Players
37
Using genome sequencing &
machine learning to
modernize infectious disease
diagnosis and treatment
GENOMICSVERY EARLY MOBILIZATION (VEMO)
By introducing robot-assisted
therapy to the ICU,
REACTIVE-ROBOTICS
support therapists and nurses
to provide the optimal VEM
therapy to their patients.
Battery-powered, handheld
diagnostic platform developed
by Two Pore Guys aims to
make time-intensive, costly
diagnostic tests simple and
inexpensive to perform
NANOTECHNOLOGY
Non-Imaging: Emerging Players